North America Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others)
The generic injectables market in North America is expected to grow from US$ 22,072.74 million in 2021 to US$ 45,208.73 million by 2028; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028.
Generic injectables are as safe and effective as innovator molecules because they are bioequivalent to their branded counterparts, but they are not patented for many reasons. These medications can be produced for commercial usage only after the patent expiration of the branded drug. As the drug molecules are similar in branded and generic formulation, no or minimal R&D cost is associated with generic injectables. The low upfront R&D costs allow drug manufacturers to sell generic injectables at lower prices. As stated by the United States Food and Drug Administration (US FDA), a single generic competitor can lead to price reductions of 30%, while five generics competing could lead to price drops of ~85%. Additionally, generic injectables saved US$ 2.2 trillion for the US healthcare system during 2009–2019. As mentioned in a report by Congressional Budget Office, the pharmaceutical industry spent US$ 83 billion on R&D in 2019. However, with generic injectables, the repetition of clinical studies is not required to demonstrate their effectiveness and safety, which contributes to their low prices. Further, the approval process for generic medicines is faster than for branded ones. As reported by the United States Food and Drug Administration (USFDA), in 2019, 107 first generic drugs and 110 complex generic drugs were approved, totaling 11% of the generic drug product approvals. Overall, in 2019, the generic drug program approved or tentatively approved 1,014 generic drug applications. Additionally, the development of a new chemical entity takes almost a decade on average, which is bypassed in the development of generic injectables. Thus, the low cost associated with generic injectables is one of the major factors attracting new players to enter the market and driving the generic injectables market.
North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
North America Generic Injectables Market Segmentation
The North America generic injectables market is segmented into product type, container type, application, route of administration, and country. Based on product type, the market has been segmented into large molecule injectable and small molecule injectable. In 2020, the large molecule injectable segment held a larger market share. In terms of container type, the market has been categorized into vials, premix, prefilled syringes, ampoules, and others. In 2020, the vials segment held the largest share of the market. Based on application, the market has been segmented into oncology, infectious diseases, cardiology, diabetes, immunology, and others. In 2020, the oncology segment held the largest share of the market. Based on route of administration, the market has been categorized into intravenous, intramuscular, subcutaneous, and others. In 2020, the intravenous segment held the largest market share. Based on country, the North America generic injectables market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2020.
AstraZeneca; Baxter International Inc.; Biocon; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Hikma Pharmaceuticals PLC; Johnson and Johnson Services, Inc.; Lupin; Merck & Co., Inc.; Pfizer Inc.; and Viatris Inc are among the leading companies in the North America generic injectables market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Generic injectables Market – By Product Type
1.3.2 North America Generic injectables Market – By Container Type
1.3.3 North America Generic injectables Market – By Application
1.3.4 North America Generic injectables Market – By Route of Administration
1.3.5 North America Generic injectables Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Generic Injectables Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Generic Injectables Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Low R&D, Marketing, and Manufacturing Costs
5.1.2 High Demand for Affordable Drugs
5.2 Market Restraints
5.2.1 Critical Inspection System for Prefilled Injection
5.3 Market Opportunities
5.3.1 Increasing Patent Expiry of Drugs
5.4 Future Trends
5.4.1 Government Support for Generic Injectables Production and Healthcare Cost Reduction
5.5 Impact Analysis
6. Generic Injectables Market– North America Analysis
6.1 North America Generic Injectables Market Revenue Forecast and Analysis
7. North America Generic Injectables Market– by Product Type
7.1 Overview
7.2 North America Generic Injectables Market, By Product Type, 2021 & 2028 (%)
7.3 Large Molecule Injectables
7.3.1 Overview
7.3.2 Large Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
7.4 Small Molecule Injectables
7.4.1 Overview
7.4.2 Small Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8. North America Generic Injectables Market– by Container Type
8.1 Overview
8.2 North America Generic Injectables Market, By Container Type, 2021 & 2028 (%)
8.3 Vials
8.3.1 Overview
8.3.2 Vials: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.4 Premix
8.4.1 Overview
8.4.2 Premix: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.5 Prefilled Syringes
8.5.1 Overview
8.5.2 Prefilled Syringes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.6 Ampoules
8.6.1 Overview
8.6.2 Ampoules: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9. North America Generic Injectables Market– by Application
9.1 Overview
9.2 North America Generic Injectables Market, By Application, 2021 & 2028 (%)
9.3 Oncology
9.3.1 Overview
9.3.2 Oncology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
9.4.1 Overview
9.4.2 Infectious Diseases: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.6 Diabetes
9.6.1 Overview
9.6.2 Diabetes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.7 Immunology
9.7.1 Overview
9.7.2 Immunology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10. North America Generic Injectables Market– by Route of Administration
10.1 Overview
10.2 North America Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)
10.3 Intravenous
10.3.1 Overview
10.3.2 Intravenous: North America North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10.4 Intramuscular
10.4.1 Overview
10.4.2 Intramuscular: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10.5 Subcutaneous
10.5.1 Overview
10.5.2 Subcutaneous: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
11. North America Generic Injectables Market– Country Analysis
11.1 North America: Generic Injectables Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.2 North America: Generic Injectables Market, by Country, 2020 & 2028 (%)
11.1.2.1 US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1 US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2 US: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.2.1.3 US: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.2.1.4 US: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.2.1.5 US: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.2 Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1 Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2 Canada: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.2.2.3 Canada: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.2.2.4 Canada: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.2.2.5 Canada: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.1.2.3 Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1 Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2 Mexico: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.2.3.3 Mexico: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.2.3.4 Mexico: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.2.3.5 Mexico: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
12. North America Generic Injectables Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 AstraZeneca
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Baxter International Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Biocon
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fresenius SE & Co. KGaA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 GlaxoSmithKline plc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals PLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Lupin
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Viatris Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Merck & Co., Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Pfizer Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Generic injectables Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. US Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 4. US Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. US Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. Organic Developments Done By Companies
Table 15. Inorganic Developments Done By Companies
Table 16. Glossary of Terms, North America Generic Injectables Market
LIST OF FIGURES
Figure 1. North America Generic injectables Market Segmentation
Figure 2. North America Generic injectables Market, By Country
Figure 3. North America Generic Injectables Market Overview
Figure 4. Large Molecule Injectable Segment Held Largest Share of Product Type Segment in North America Generic injectables Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Generic injectables Market Impact Analysis of Driver and Restraints
Figure 9. North America Generic Injectables Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Generic Injectables Market, by Product Type, 2021 & 2028 (%)
Figure 11. Large Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Small Molecule Injectables: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Generic Injectables Market, by Container Type, 2021 & 2028 (%)
Figure 14. Vials: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Premix: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Prefilled Syringes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Ampoules: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Generic Injectables Market, by Application, 2021 & 2028 (%)
Figure 20. Oncology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Infectious Diseases: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Cardiology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Diabetes: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Immunology: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)
Figure 27. Intravenous: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Intramuscular: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Subcutaneous: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: North America Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. North America: Generic Injectables Market, by Country, 2020 & 2028 (%)
Figure 33. US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Generic Injectables Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Generic Injectables Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Generic Injectables Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution